News Biogen’s Tau-Targeting Alzheimer’s Data Show Promise — and Raise Questions pharminent July 14, 2026
Clinical Data Biogen data highlight promise, questions surrounding tau-targeting Alzheimer’s drugs pharminent July 14, 2026
M&A / Deals Novartis and Chai Discovery collaborate on antibody identification pharminent July 14, 2026
Policy / Pricing Germany approves healthcare costs overhaul despite significant pharma opposition pharminent July 13, 2026
News Roche Scraps Two Ionis-Partnered Huntington’s Studies After Tominersen Failure pharminent July 10, 2026
Pipeline AAIC 2026: Tau-targeted Alzheimer’s treatments heat up while amyloid therapies persist pharminent July 10, 2026
M&A / Deals Teva and Polpharma Biologics sign global deal for ocrelizumab biosimilar pharminent July 10, 2026
Clinical Data AstraZeneca, Ionis drug fails big heart disease study in major setback pharminent July 9, 2026
Regulatory FDA freezes CRL trove as ‘radical transparency’ push hits speedbump pharminent July 9, 2026
News Sino Biopharm Strikes Drug Licensing Deal With AstraZeneca, Deepens Partnership With GSK pharminent July 8, 2026
M&A / Deals AstraZeneca bets up to $1.9B in respiratory disease collab with Sino Biopharmaceutical pharminent July 8, 2026
Commercial Wegovy pill launches in UK as first daily oral GLP1 for weight management pharminent July 6, 2026
News BioNTech Held Buyer Talks Over Four German Sites Set to Close, Handelsblatt Reports pharminent July 3, 2026
News Roche’s Divarasib Beats Amgen and BMS Head-to-Head in Phase 3 KRAS Lung Cancer Trial pharminent July 2, 2026
Regulatory Novartis receives European Commission approval for Itvisma for spinal muscular atrophy pharminent July 2, 2026
